Go to Page # Page of 35

Immunotherapy for Cancer: Promises and Challenges

 Edmund K. Waller MD PhD FACP
  4th-Jul-2016
Description: Cancer is a genetic disease that results from sequential mutations. Why don’t vaccines work better to treat cancer? Immunity is a balance between action and restraint. Signaling pathways between T-cells and dendritic cells regulate T-cell activation status. Activity of Anti–PD-1 Antibody in Patients with Treatment-Refractory Melanoma, Non–Small-Cell Lung Cancer, or Renal-Cell Cancer. Activity of Anti–PD-L1 Antibody in Patients with Advanced Melanoma and Non–Small-Cell Lung Cancer. Relationship between PD-L1 Expression and response rates in lung cancer.
Views: 1101
Domain: Medical
Category: Therapy
Contributing Organization: World Stem Cell Summit
 ‐ More of their Presentations
Semiconductor Analytics
Contents:
Immunotherapy for Cancer
Promises and Challenges
Edmund K. Waller, MD, PhD, FACP

Cancer is a genetic disease that
results from sequential mutations

Types of Tumor Antigens Recognized by T Cells

Cancer Immunotherapy has been
disappointing

Why don’t vaccines work better to treat cancer?
Immunity is a balance between action and restraint

Signaling pathways between T-cells and dendriti ... See more

Recent Presentations

Jeff Olsen MD
15 December, 2017
...
14 December, 2017
...
13 December, 2017